3/31
12:31 pm
tnxp
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Phase 1 Data for Lyme Disease Candidate TNX-4800, Plans Phase 2 Study [TheStreet.com]
Medium
Report
InvestorNewsBreaks – Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Reports Phase 1 Data for Lyme Disease Candidate TNX-4800, Plans Phase 2 Study [TheStreet.com]
3/31
07:20 am
tnxp
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026 [Yahoo! Finance]
High
Report
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026 [Yahoo! Finance]
3/31
07:00 am
tnxp
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026
Medium
Report
Tonix Pharmaceuticals Announces Presentation of Phase 1 Data and Outlines Planned Adaptive Phase 2 Field Study of TNX-4800 for the Prevention of Lyme Disease, at the World Vaccine Congress Washington 2026
3/30
07:02 am
tnxp
Wall Street Breakfast Podcast: Mistral Loads Up On Nvidia [Seeking Alpha]
Medium
Report
Wall Street Breakfast Podcast: Mistral Loads Up On Nvidia [Seeking Alpha]
3/28
01:05 am
tnxp
Medium
Report
3/26
07:00 am
tnxp
Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain
Medium
Report
Tonix Pharmaceuticals Announces First Participant Dosed in Phase 1 Investigator-Initiated Pharmacodynamic Study of TNX-1900 (Intranasal Potentiated Oxytocin) to Assess Potential for Treating Migraine and Craniofacial Pain
3/23
05:09 pm
tnxp
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026 [Yahoo! Finance]
Medium
Report
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026 [Yahoo! Finance]
3/23
04:32 pm
tnxp
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026
Medium
Report
Tonix Pharmaceuticals Announces Presentations at World Vaccine Congress Washington 2026
3/18
08:06 pm
tnxp
Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026 [Yahoo! Finance]
Medium
Report
Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026 [Yahoo! Finance]
3/18
04:58 pm
tnxp
Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026
High
Report
Tonix Pharmaceuticals to Present at BIO-Europe Spring 2026
3/17
05:14 pm
tnxp
Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 [Yahoo! Finance]
Medium
Report
Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026 [Yahoo! Finance]
3/17
04:35 pm
tnxp
Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
Medium
Report
Tonix Pharmaceuticals Announces Oral Presentation and Two Poster Presentations on Preclinical Immuno-oncology Portfolio at the American Association for Cancer Research (AACR) Annual Meeting 2026
3/17
10:07 am
tnxp
Tonix Q4: Revenue Beat, EPS Miss, Early Signs Of Tonmya Momentum [Seeking Alpha]
Medium
Report
Tonix Q4: Revenue Beat, EPS Miss, Early Signs Of Tonmya Momentum [Seeking Alpha]
3/13
05:23 am
tnxp
Tonix Pharmaceuticals GAAP EPS of -$3.98 misses by $0.82, revenue of $5.39M beats by $2.42M [Seeking Alpha]
Low
Report
Tonix Pharmaceuticals GAAP EPS of -$3.98 misses by $0.82, revenue of $5.39M beats by $2.42M [Seeking Alpha]
3/12
06:03 pm
tnxp
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights [Yahoo! Finance]
Low
Report
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights [Yahoo! Finance]
3/12
05:30 pm
tnxp
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Low
Report
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
3/10
08:00 am
tnxp
Tonix Pharmaceuticals Presented Post Hoc Analyses of Phase 3 Data on TONMYATM at the 8th International Congress on Controversies in Fibromyalgia
Low
Report
Tonix Pharmaceuticals Presented Post Hoc Analyses of Phase 3 Data on TONMYATM at the 8th International Congress on Controversies in Fibromyalgia
3/9
05:07 pm
tnxp
Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting [Yahoo! Finance]
Low
Report
Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting [Yahoo! Finance]
3/9
04:30 pm
tnxp
Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting
Low
Report
Tonix Pharmaceuticals Presented Data on TONMYATM in Treating Patients with Fibromyalgia at the 2026 AAPM PainConnect Annual Meeting
3/5
04:57 pm
tnxp
Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development [Yahoo! Finance]
Low
Report
Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development [Yahoo! Finance]
3/5
04:15 pm
tnxp
Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development
Low
Report
Tonix Pharmaceuticals Announces Publication of Clinical Pharmacokinetic Studies of TONMYA™ and Prototype Formulations in the Journal Clinical Pharmacology in Drug Development
3/3
05:00 pm
tnxp
Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting [Yahoo! Finance]
Low
Report
Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting [Yahoo! Finance]
3/3
04:30 pm
tnxp
Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting
Low
Report
Tonix Pharmaceuticals to Present Poster on Tonmya™ at the 2026 American Academy of Pain Medicine PainConnect Annual Meeting
3/3
06:37 am
tnxp
Tonix Pharmaceuticals Announces Uplisting from Nasdaq Capital Market to Nasdaq Global Select Market [Yahoo! Finance]
Low
Report
Tonix Pharmaceuticals Announces Uplisting from Nasdaq Capital Market to Nasdaq Global Select Market [Yahoo! Finance]
3/3
06:00 am
tnxp
Tonix Pharmaceuticals Announces Uplisting from Nasdaq Capital Market to Nasdaq Global Select Market
Low
Report
Tonix Pharmaceuticals Announces Uplisting from Nasdaq Capital Market to Nasdaq Global Select Market